Pneumococcal Vaccine Market Research 2024-2030: Prevnar 13, VAXNEUVANCE, PNEUMOSIL Size, Share & Trends Analysis
September 06, 2024 07:17 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type, Product (Prevnar 13, VAXNEUVANCE, PNEUMOSIL), End-use...
2024 Market Research: Vaccines Market Projected to Reach USD 116.63 Billion by 2027 - Rising Disease Prevalence and Prophylactic Applications Fueling Growth
September 06, 2024 05:57 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Vaccine Adjuvants Strategic Research Report 2024
September 05, 2024 04:05 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
Global Cholera Vaccines Market - Global Inactivated Vaccine, Live Attenuated Vaccine, Injectable Vaccines, Oral Vaccines Forecast 2024-2030
August 30, 2024 04:05 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines),...
Dengue Vaccine Research Report 2024 with Focus on 40+ Players Including Biological E, GSK, Instituto Butantan, Panacea Biotec, Sanofi, Takeda, Vabiotech - Market Forecast to 2030
August 28, 2024 11:07 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Dengue Vaccine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Dengue Vaccine was...
H1N1 Vaccines Strategic Research Report 2024: Increasing Influenza Outbreaks and Viral Mutations Accelerates Demand - Global Market Forecast to 2030
August 28, 2024 04:27 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for H1N1 Vaccines is...
Dog Vaccine Market Research 2024 - Global $2+ Billion Industry Trends, Opportunities & Forecasts, 2019-2029F
August 28, 2024 04:19 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Dog Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Aquaculture Vaccines Market Research 2024 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2029F
August 28, 2024 04:18 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Aquaculture Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Vaccine Contract Manufacturing Industry Report 2024-2035: The Advent of Virus-like Particles (VLPs)
August 20, 2024 12:16 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others),...
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 08, 2024 19:20 ET
|
HilleVax, Inc.
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine...